Phase 1 pharmacoscintigraphic study of centanafadine (QSC201589)

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  271217

• Contact name

  Litza McKenzie

• Contact email

  litza.mckenzie@quotientsciences.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2019-003326-25

• Duration of Study in the UK

  0 years, 5 months, 22 days

• Research summary

  Publication of this data is currently deferred.

• REC name

  Wales REC 2

• REC reference

  19/WA/0245

• Date of REC Opinion

  12 Sep 2019

• REC opinion

  Favourable Opinion